Lv51
1054 积分 2023-08-14 加入
26-A-11834-ACC ART101 A SIRNA TARGETING ANGIOTENSINOGEN DEMONSTRATES DURABLE TARGET INHIBITION AND BLOOD PRESSURE LOWERING IN HEALTHY SUBJECTS
3天前
求助中
Abstract 4362610: Safety, Pharmacokinetics, and Pharmacodynamics of SGB-3908, A siRNA Targeting AGT in Healthy and Mildly Hypertensive Subjects
3天前
求助中
Development and comparison of model-integrated evidence approaches for bioequivalence studies with pharmacokinetic end points
6天前
已完结
Statistical issues in a modeling approach to assessing bioequivalence or PK similarity with presence of sparsely sampled subjects
6天前
已完结
Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken
8天前
已完结
Optimizing Body Size‐Based Dosing Approaches for Antibody–Drug Conjugates
15天前
已完结
Likelihood based approaches to handling data below the quantification limit using NONMEM VI
15天前
已完结
Impact of censoring data below an arbitrary quantification limit on structural model misspecification
15天前
已完结
Ways to Fit a PK Model with Some Data Below the Quantification Limit
15天前
已完结
Discordance Between Child‐Pugh and National Cancer Institute Classifications for Hepatic Dysfunction: Implications on Dosing Recommendations for Oncology Compounds
15天前
已完结
皖公网安备34019202002308
